SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,969.00
0.00 (0.00%)
At close: Oct 10, 2025

SLS BIO Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2015FY 2014
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '15 Dec '14
26,88926,28835,23333,970--
Market Cap Growth
-16.57%-25.39%3.72%---
Enterprise Value
20,82018,91733,62836,114--
Last Close Price
1969.001925.002554.402462.82--
PE Ratio
-78.3324.5712.02--
PS Ratio
3.693.143.913.16--
PB Ratio
2.422.102.625.07--
P/TBV Ratio
2.452.132.675.20--
P/FCF Ratio
-97.3916.3010.25--
P/OCF Ratio
28.8115.2310.268.42--
EV/Sales Ratio
2.852.263.733.36--
EV/EBITDA Ratio
61.7511.6514.569.69--
EV/EBIT Ratio
-65.7732.6214.90--
EV/FCF Ratio
-39.5570.0815.5610.90--
Debt / Equity Ratio
0.140.140.160.380.834.39
Debt / EBITDA Ratio
4.751.050.910.683.613.68
Debt / FCF Ratio
-6.340.970.7642.096.16
Asset Turnover
0.460.490.61-0.66-
Inventory Turnover
28.2928.1120.82---
Quick Ratio
6.776.456.572.731.240.60
Current Ratio
7.016.646.772.971.260.61
Return on Equity (ROE)
-12.45%2.58%14.22%-6.63%-
Return on Assets (ROA)
-3.85%1.05%4.35%-3.45%-
Return on Capital (ROIC)
-4.36%1.21%5.20%-4.22%-
Return on Capital Employed (ROCE)
-1.90%6.40%25.00%7.50%20.80%
Earnings Yield
-5.72%1.28%4.07%8.32%--
FCF Yield
-1.96%1.03%6.13%9.76%--
Payout Ratio
-114.33%----
Buyback Yield / Dilution
16.34%-8.73%-104.97%-37.54%-14.68%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.